Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2001-04-06
Original market date: See footnote 1
1993-12-31
Product name:
TRIAMINIC EXPECTORANT DH SYRUP
DIN:
01906615 Electronic product monograph is not available
Company:
NOVARTIS CONSUMER HEALTH CANADA INC.
500
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Syrup
Route(s) of administration:
Oral
Number of active ingredient(s):
5
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
48:08.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Active ingredient group (AIG) number:See footnote5
0503200001
Active ingredient(s) | Strength |
---|---|
GUAIFENESIN | 100 MG / 5 ML |
HYDROCODONE BITARTRATE | 1.67 MG / 5 ML |
PHENIRAMINE MALEATE | 6.25 MG / 5 ML |
PHENYLPROPANOLAMINE HYDROCHLORIDE | 12.5 MG / 5 ML |
PYRILAMINE MALEATE | 6.25 MG / 5 ML |